Clobazam Suspension
Product Images NDC 72162-2608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 72162-2608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Clobazam Fig1)

FDA Label Image

Figure-10 (Clobazam Fig10)

FDA Label Image

Figure-11 (Clobazam Fig11)

FDA Label Image

Figure (Clobazam Fig2)

Figure (Clobazam Fig2)
This text provides a table showing the reduction in weekly drop seizure frequency from baseline for different doses of Clobazam (Low, Medium, High) and Placebo. The values are presented in percentages.*
FDA Label Image

Figure-3 (Clobazam Fig3)

Figure-3 (Clobazam Fig3)
This is a list of items which includes a bottle, syringes, and a bottle adapter. These items are likely related to medical or laboratory use.*
FDA Label Image

Figure-4 (Clobazam Fig4)

FDA Label Image

Figure-5 (Clobazam Fig5)

FDA Label Image

Figure-6 (Clobazam Fig6)

Figure-6 (Clobazam Fig6)
This text mentions dosage indicators located on the plunger and the edge of the plunger barrel. These indicators are likely used to measure and administer precise amounts of medication or substance.*
FDA Label Image

Figure-7 (Clobazam Fig7)

FDA Label Image

Figure-4 (Clobazam Fig8)

FDA Label Image

Figure-9 (Clobazam Fig9)

FDA Label Image

Chemical Structure (Clobazam Str)

FDA Label Image

Label (Lbl721622608)

Label (Lbl721622608)
This is a description of an oral suspension liquid containing 2.5 mg of Clobazam per mL, supplied with two 10 mL syringes for administration. The product is recommended to be stored at 20° to 25°C (68° to 77°F) and should be shaken well before each use. The pharmacist is advised to provide the Medication Guide and Instructions for Use to each patient. The oral suspension should be stored in the original container in an upright position and used within 90 days of opening, discarding any remaining liquid after that time.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.